The use of injectable nitroglycerin in the cardiac catheterization laboratory. Nitroglycerin in cardiac catheterization.
At our institution, injectable nitroglycerin (TNG) has been employed during cardiac catheterization since 1976. Initially, it was primarily used in patients undergoing a provocative test for coronary spasm with ergonovine maleate. After the initial favorable experience, the use of injectable TNG became routine.
D000208:Acute Disease; D001157:Arterial Occlusive Diseases / Q000175:diagnosis; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization / Q000379:methods*; D002908:Chronic Disease; D003327:Coronary Disease / Q000175:diagnosis; D003329:Coronary Vasospasm / Q000175:diagnosis / Q000000981:diagnostic imaging; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000175:diagnosis; D005996:Nitroglycerin / Q000008:administration & dosage / Q000009:adverse effects; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D011859:Radiography
D005996:Nitroglycerin